The Rising Impact of GLP-1 Weight-Loss Drugs on Healthcare and Economy
Insurers are increasingly restricting coverage for expensive GLP-1 weight loss drugs due to high costs and demand, leading to some patients being tapered off medication or switching drugs, despite research suggesting indefinite use may be necessary for sustained benefits.